ANNUAL REPORT 2011

The mandate of the Patented Medicine Prices Review Board is to ensure that prices at which patentees sell their patented medicines in Canada are not excessive; and to report on pharmaceutical trends of all medicines and on R&D spending by patentees.

Table Of Contents

1. Statistical Highlights 2011
2. Letter to the Minister
3. Chairperson’s Message
4. About the Patented Medicine Prices Review Board
5. Regulating Prices of Patented Medicines
6. Trends in Sales of Patented Drug Products
7. Price Trends
8. Comparison of Canadian Prices to Foreign Prices
9. Utilization of Patented Drug Products
10. Canadian Drug Expenditures in the Global Context
11. Analysis of Research and Development Expenditures
12. National Prescription Drug Utilization Information System
13. Appendix 1: Glossary
14. Appendix 2: Patented Drug Products First Reported to the PMPRB in 2011
15. Appendix 3: Research and Development

View Full Report